Study title: The growth of the internal genitalia and the bone mineralization during hormonal replacement therapy and the presence of aortic root dilatation in girls with Turner Syndrome
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] | |||||
Brands: | |||||
MAH holders: | |||||
Assessment: | |||||
Active substance: ESTRADIOL HEMIHYDRATE/ NORETHISTERONE ACETATE | |||||
ATC code: G03 FB 05 | |||||
Document link: | |||||
Document date: | |||||
Study number: 2004-004778-99 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |